Abstract

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is characterized by the inflammation of small and medium vessels and presence of proteinase 3-ANCA or myeloperoxidase-ANCA in the circulation. AAV comprises three clinical subtypes: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic GPA (EGPA). Although the pathogenesis of AAV is still unclear, genetic and environmental factors and the immune system are thought to be involved. Genetic factors have been confirmed to play an important role in AAV. Genome-wide association studies have identified numerous genetic variants in MHC and non-MHC regions associated with AAV. The strongest evidence of MHC association in AAV is human leukocyte antigen (HLA)-DP. A significant association between AAV and genetic variations in non-MHC regions, such as CTLA-4, FCGR2A, PTPN22, SERPINA1, and TLR9 has also been found. Moreover, different clinical subtypes of AAV have distinct genetic backgrounds. GPA is associated with HLA-DP1, MPA with HLA-DQ, and EGPA with HLA-DRB4. These findings could help elucidate the etiology of AAV and develop new biomarkers for diagnosis and targeted therapy. Herein, we briefly summarize the updates on the genetic pathogenesis and biomarkers of AAV.

Highlights

  • Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a complex systemic autoimmune disease presenting with the inflammation of small and medium vessels that results in vascular destruction and tissue necrosis [1, 2]

  • granulomatosis with polyangiitis (GPA) is predominantly associated with proteinase 3 (PR3)-ANCA, Genetics of ANCA-Associated Vasculitides while microscopic polyangiitis (MPA) and eosinophilic GPA (EGPA) are predominantly associated with MPOANCA, but are occasionally ANCA-negative [4]

  • The epidemiological manifestations of AAV differ among geographical regions; GPA and PR3-ANCA AAV are more common in Europeans, while MPA and MPOANCA AAV are more common in Asians [5]

Read more

Summary

INTRODUCTION

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a complex systemic autoimmune disease presenting with the inflammation of small and medium vessels that results in vascular destruction and tissue necrosis [1, 2]. GPA is predominantly associated with PR3-ANCA, Genetics of ANCA-Associated Vasculitides while MPA and EGPA are predominantly associated with MPOANCA, but are occasionally ANCA-negative [4]. The epidemiological manifestations of AAV differ among geographical regions; GPA and PR3-ANCA AAV are more common in Europeans, while MPA and MPOANCA AAV are more common in Asians [5]. We mainly discuss the genetic studies on AAV, focusing on the identified susceptibility genes or loci to enrich our understanding of the disease

GENETIC APPROACHES FOR AAV
HLA Region
MPA EGPA
CONCLUSION
Findings
AUTHOR CONTRIBUTIONS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.